Paraneoplastic limbic encephalitis following treatment with single-agent pembrolizumab for advanced gastroesophageal adenocarcinoma
10.1136/bcr-2021-247676
May 24, 2022
10.1136/bcr-2021-247676
May 24, 2022
10.1136/bcr-2021-246841
May 19, 2022
10.1136/bcr-2021-247346
May 19, 2022
10.1136/bcr-2021-248415
May 13, 2022
10.1136/bcr-2021-246770
May 11, 2022
10.1136/bcr-2021-245749
April 29, 2022
10.1136/bcr-2021-247996
April 6, 2022
10.1136/bcr-2022-249237
March 30, 2022
10.1136/bcr-2021-245603
March 29, 2022
10.1136/bcr-2021-247576
March 24, 2022